Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-17-000010
Filing Date
2017-11-09
Accepted
2017-11-08 18:00:19
Documents
74
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-9302017x10q.htm 10-Q 1101854
2 EXHIBIT 10.1 mgen-9302017xex102servier.htm EX-10.1 23609
3 EXHIBIT 10.2 a102yaletouploadctr.htm EX-10.2 3240
4 EXHIBIT 31.1 mgen-9302017xex311.htm EX-31.1 12425
5 EXHIBIT 31.2 mgen-9302017xex312.htm EX-31.2 12540
6 EXHIBIT 32.1 mgen-9302017xex321.htm EX-32.1 14718
13 a102yaletouploadctr001.jpg GRAPHIC 147296
  Complete submission text file 0001590750-17-000010.txt   5931632

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mgen-20170930.xml EX-101.INS 897270
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20170930.xsd EX-101.SCH 51076
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20170930_cal.xml EX-101.CAL 68184
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20170930_def.xml EX-101.DEF 307915
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20170930_lab.xml EX-101.LAB 640406
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20170930_pre.xml EX-101.PRE 402822
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 171187742
SIC: 8071 Services-Medical Laboratories